Feedback / Questions
bryostatin 1 (NSC 339555) - Synaptogenix
https://www.prnewswire.com/news-releases/synaptogenix-announces-topline-results-from-nih-sponsored-phase-2-clinical-trial-of-bryostatin-1-for-advanced-alzheimers-disease-301704807.html
Dec 16, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next